Key result
Left atrial appendage closure with the WATCHMAN device achieved a 77% relative risk reduction in stroke, transient ischaemic attack, or systemic embolism compared to expected rates over 2 years.
Why the study?
Left atrial appendage closure is an alternative for stroke prevention in high-risk non-valvular atrial fibrillation, but has not been widely studied in Asian patients.
Does left atrial appendage closure with the WATCHMAN device reduce stroke and bleeding compared to expected rates in Asian patients with non-valvular atrial fibrillation?
Observational (n=201)
Yes
Does left atrial appendage closure with the WATCHMAN device reduce stroke and bleeding compared to expected rates in Asian patients with non-valvular atrial fibrillation?
Real-world registry data demonstrates that left atrial appendage closure with the WATCHMAN device is safe and effective for stroke and bleeding prevention in Asian patients with non-valvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Supports LAA closure feasibility in Asian non-valvular AF; leaves open randomized comparison versus anticoagulation.
Left atrial appendage closure is a non-pharmacological alternative for stroke prevention in high-risk non-valvular atrial fibrillation patients, but has not been widely studied in Asian patients. The prospective WASP registry assessed real-world outcomes for patients undergoing WATCHMAN implant in the Asia-Pacific region. Data were collected from consecutive patients across 9 centres. Major endpoints included procedural success, safety and long-term outcomes including occurrence of bleeding, stroke/transient ischaemic attack/systemic embolism and all-cause mortality. Subjects (n = 201) had a mean age of 70.8 ± 9.4 years, high stroke risk (CHA2DS2-VASc: 3.9 ± 1.7), elevated bleeding risk (HAS-BLED: 2.1 ± 1.2) with 53% patients from Asian countries. Successful implantation occurred in 98.5% of patients; 7-day device/procedure-related SAE rate was 3.0%. After 2 years of follow-up, the rates of ischaemic stroke/TIA/SE and major bleeding were 1.9 and 2.2 per 100-PY, respectively, representing relative reductions of 77% and 49% versus expected rates per risk scores. The relative risk reductions versus expected rates were more pronounced in Asians vs. Non-Asians (89% vs 62%; 77% vs 14%). Other significant findings included larger mean LAA ostium diameter for Asians vs. Non-Asians (23.4 ± 4.1 mm vs. 21.2 ± 3.2 mm, p < 0.001) and hence requirement for larger median device size (27 mm for Asians, 24 mm for non-Asians [p < 0.0001]). Real-world experience of left atrial appendage closure with WATCHMAN has demonstrated low peri-procedural risk, and long-term efficacy for stroke and bleeding prevention in a primarily Asian cohort.
No takes yet. Share an insight, caveat, or question.
Phillips et al. (2019) conducted an observational in Non-valvular atrial fibrillation (n=201). Left atrial appendage closure with WATCHMAN device vs. Expected rates based on CHA2DS2-VASc score was evaluated on Ischaemic stroke, transient ischaemic attack, or systemic embolism (77% relative risk reduction). Left atrial appendage closure with the WATCHMAN device achieved a 77% relative risk reduction in stroke, transient ischaemic attack, or systemic embolism compared to expected rates over 2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: